S-1 in combination with CPT-11 plus trastuzumab for pretreated HER2+metastatic breast cancer

被引：0
|
作者：
Toh, U. [1 ]
Iwakuma, N. [1 ]
Mishima, M. [1 ]
Furukawa, M. [1 ]
Fujii, T. [1 ]
Ogo, E. [2 ]
Nakagawa, S. [3 ]
Tanaka, M. [4 ]
Akagi, Y. [1 ]
机构：
[1] Kurume Univ, Sch Med, Surg, Kurume, Fukuoka 830, Japan
[2] Kurume Univ, Sch Med, Radiol, Kurume, Fukuoka 830, Japan
[3] Natl Hosp Org, Kyushu Med Ctr, Breast Surg, Fukuoka, Japan
[4] Kurume Gen Hosp, Breast Surg, Kurume, Fukuoka, Japan
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70059-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P008
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [1] Bevacizumab plus trastuzumab for treatment of HER2+metastatic breast cancer
    De Amuriza Chicharro, N.
    Gastalver Martin, C.
    Goyache Goni, M. P.
    Cortijo Cascajares, S.
    Garcia Munoz, C.
    Ferrari Piquero, J. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 984 - 985
  • [2] Phase 1 study of CPT-11 plus S-1 for patients with metastatic gastric cancer
    Tsujinaka, T
    Narahara, H
    Takiuchi, H
    Furukawa, H
    Taguchi, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 426 - 426
  • [3] A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+metastatic breast cancer progressing on trastuzumab therapy
    O'Shaughnessy, J.
    Blackwell, K. L.
    Burstein, H.
    Storniolo, A. M.
    Sledge, G.
    Baselga, J.
    Koehler, M.
    Laabs, S.
    Florance, A.
    Roychowdhury, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Study of the combination gemcitabine and trastuzumab in the treatment of HER2+metastatic breast cancer
    Menjon-Beltran, S.
    Olivencia-Dueso, R.
    Gonzalez-Jimenez, E.
    Titos, M. J.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [5] A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer
    Yamaguchi, Yoshiyuki
    Minami, Kazuhito
    Kawabuchi, Yoshiharu
    Ohshita, Akiko
    Hironaka, Katsuji
    HEPATO-GASTROENTEROLOGY, 2008, 55 (82-83) : 407 - 411
  • [6] STUDY OF S-1/TRASTUZUMAB COMBINATION THERAPY FOR HER2-POSITIVE METASTATIC BREAST CANCER
    不详
    ANNALS OF ONCOLOGY, 2010, 21 : 64 - 64
  • [7] Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer
    Nakafusa, Yuji
    Tanaka, Masayuki
    Ohtsuka, Takao
    Miyoshi, Atsushi
    Kohya, Naohiko
    Kitajima, Yoshihiko
    Sato, Seiji
    Mochinaga, Sakiko
    Dohi, Sawako
    Miyazaki, Kohji
    MOLECULAR MEDICINE REPORTS, 2008, 1 (06) : 925 - 930
  • [8] Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
    Nakayama, Takahiro
    Morita, Satoshi
    Takashima, Tsutomu
    Kamigaki, Shunji
    Yoshidome, Katsuhide
    Ito, Toshikazu
    Taguchi, Tetsuya
    Sakamoto, Junichi
    Noguchi, Shinzaburo
    ANTICANCER RESEARCH, 2011, 31 (09) : 3035 - 3039
  • [9] Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
    Takashima, Tsutomu
    Nakayama, Takahiro
    Yoshidome, Katsuhide
    Kawajiri, Hidemi
    Kamigaki, Shunji
    Tsurutani, Junji
    Arai, Takashi
    Ito, Toshikazu
    Komoike, Yoshihumi
    Doi, Takako
    Masuda, Norikazu
    Miyauchi, Keisuke
    Miyoshi, Yasuo
    Sakamoto, Junichi
    Morita, Satoshi
    Taguchi, Tetsuya
    ANTICANCER RESEARCH, 2014, 34 (07) : 3583 - 3588
  • [10] Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer
    Takiuchi, Hiroya
    GASTRIC CANCER, 2009, 12 : 55 - 59
12345